Tender for the Operating Lease of Biological Atomic Force Microscopy (bioAFM)

A Contract Award Notice
by SWANSEA UNIVERSITY

Source
OJEU
Type
Contract (Supply)
Duration
19 month (est.)
Value
___
Sector
INDUSTRIAL
Published
12 Mar 2021
Delivery
01 Apr 2020 to 31 Oct 2021 (est.)
Deadline
n/a

Concepts

Location

Swansea University Medical School — Singleton Campus

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

The Cluster for Epigenomics and Antibody drug conjugate (ADC) Therapeutics (CEAT) is a GBP 2.6 million project, led by the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School and is aimed at developing new therapeutics for the treatment of ovarian cancer. A key output of the CEAT project is to establish a developmental pipeline for bioAFM applications in clinically acceptable in vitro and ex-vivo disease models, providing molecular, cellular and tissue level morphological, topographical and biomechanical information to support epigenomic investigations and the development of advanced therapeutics. As part of this requirement we have identified the need to loan specific bioAFM advanced technology from a reputable, commercial supplier, providing hybrid instrumentation compatible with current bioAFM facilities within SUMS.

Total Quantity or Scope

He Cluster for Epigenomics and Antibody drug conjugate (ADC) Therapeutics (CEAT) is a GBP 2.6 million project, led by the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School and is aimed at developing new therapeutics for the treatment of ovarian cancer. A key output of the CEAT project is to establish a developmental pipeline for bioAFM applications in clinically acceptable in vitro and ex-vivo disease models, providing molecular, cellular and tissue level morphological, topographical and biomechanical information to support epigenomic investigations and the development of advanced therapeutics. As part of this requirement we have identified the need to loan specific bioAFM advanced technology from a reputable, commercial supplier, providing hybrid instrumentation compatible with current bioAFM facilities within SUMS

Award Detail

1 Unnamed (None)
  • Reference: su135(20)
  • CONTRACT NOT AWARDED – PROCUREMENT DISCONTINUED.

Award Criteria

PRICE _

CPV Codes

  • 38510000 - Microscopes
  • 66114000 - Financial leasing services

Indicators

  • Award on basis of price.

Other Information

The funding for this equipment is on the basis of an Operating Lease for the duration of the project (WA Ref:108879)

Reference

Domains